Drug Profile
Ethinylestradiol/levonorgestrel transdermal - Agile Therapeutics
Alternative Names: AG 200 ER; AG 200 ER (SmP); AG 200 SP; AG-200-15; AG200 15 (SmP); Ethinyl estradiol and levonorgestrel transdermal system; Low dose EE/LNG; TwirlaLatest Information Update: 22 Aug 2022
Price :
$50
*
At a glance
- Originator Agile Therapeutics
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 01 Aug 2022 Agile Therapeutics and Nurx agrees for supply of Ethinylestradiol/levonorgestrel
- 10 Jan 2022 Agile Therapeutics and Afaxys Pharma enters into partnership agreement for the promotion of ethinylestradiol and levonorgestrel transdermal system in the USA
- 07 Dec 2020 Launched for Pregnancy (Prevention) in USA (Transdermal)